New Study Reveals Twice-Daily Radiation Improves Quality of Life for Lung Cancer Patients

{"heading_1":"Twice-Daily Radiation's Impact","paragraph_1":"The study, called NRG-LU005, examined the effects of adding the immunotherapy drug atezolizumab to standard chemotherapy and radiation for small-cell lung cancer.","paragraph_2":"While the drug did not improve survival rates, the researchers found that patients who received radiation twice daily reported a much higher quality of life and better long-term survival.","paragraph_3":"The study tracked 544 patients who completed surveys about their fatigue, physical health, and daily struggles during and after treatment.","paragraph_4":"Patients who received radiation twice daily reported a steadier quality of life over time, with fewer declines compared to those who received radiation once daily.","paragraph_5":"The researchers noted that other health factors may have influenced the results, but the findings offer hope for improving treatment options for lung cancer patients."}